Mengke Sheng

Mengke Sheng

Auto-generated profile, based on publicly available information

Mengke Sheng

School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
XWXiaowen Wu
Xiaowen Wu
XDXingxing Dai
Xingxing Dai
YLYuyao Liao
Yuyao Liao
MSMengke Sheng
Mengke Sheng
XSXinyuan Shi
Xinyuan Shi

17 December 2020 in Research Square
Verified
Preprint
Open access
PDF file
MSMengke Sheng
Mengke Sheng
XLXing Liu
Xing Liu
QQQingsong Qu
Qingsong Qu
XWXiaowen Wu
Xiaowen Wu
YLYuyao Liao
Yuyao Liao
XSXinyuan Shi
Xinyuan Shi
Background: Chronic cough significantly affects human health and quality of life. Studies have shown that Sanao Decoction(SAD)can clinically treat chronic cough. To investigate its mechanisms, we used the method of network pharmacology to conduct research at the molecular level.Methods: The active ingredients and their targets were screened by pharmacokinetics parameters from the traditional Chinese medicine system pharmacology analysis platform (TCMSP). The relevant targets of chronic cough were obtained from two databases: GeneCards and DrugBank. Take the intersection to get potential targets of SAD to treat chronic cough and establish the component-target regulatory network by CytoScape3.7.2 and protein-protein interaction (PPI) network by STRING 1.0. The function of the target gene and related pathways were analyzed by the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) in the Database for Annotation, Visualization, and Integrated Discovery (DAVID). The significant pathways and their relevant targets were obtained and the target-pathway network was established by CytoScape3.7.2. Finally, molecular docking of the core active components and relevant targets was performed.Results: A total of 98 active components, 113 targets were identified. The component-target and target-pathway network of SAD and PPI network were established. Enrichment analysis of DAVID indicated that 2062 terms were in biological processes, 77 in cellular components, 142 in molecular functions and 20 significant pathways. In addition, the molecular docking showed that quercetin and luteolin had a good combination with the corresponding targets.Conclusions: It indicates that the active compounds of SAD, such as quercetin, luteolin, may act on AKT1, MAPK1, RELA, EGFR, BCL2 and regulate PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications and Fluid shear stress and atherosclerosis pathway to exert the effects of anti-inflammatory, anti-airway remodeling, anti-oxidant stress and repair airway damage to treat chronic cough.